COMMUNIQUÉS West-GlobeNewswire

ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
09/09/2026
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. ( [...]
GENFIT présente le potentiel commercial à long terme de sa technologie de diagnostic dans la MASH
09/09/2026
Un test sanguin simple, fiable et déployable à grande échelle permettrait d’identifier les patients atteints de MASH à risque parmi les près de 90 millions d’Américains bénéficiant d’un suivi médical en raison de [...]
GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology
09/09/2026
Simple, reliable and scalable blood-based testing could identify patients with at-risk MASH among nearly 90 million U.S. individuals receiving medical attention due to MASLD-related risk factors IQVIA estimates U.S peak [...]
Pharming Group to participate in September investor conferences
09/09/2026
Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the [...]
Allegro’s Hydrocelin significantly improves knee osteoarthritis pain and function in clinical trial
09/09/2026
Nanotechnology-based injection significantly improved knee pain and function with favorable safety and efficacy sustained over 6 months following a single administration Feasibility trial in Belgium completed [...]
ICG-21 Opens in Shenzhen, Spotlighting Bio-Generative Intelligence for Health and New Frontiers in Genomics
09/09/2026
SHENZHEN, China, Sept. 08, 2026 (GLOBE NEWSWIRE) -- The 21st Annual Meeting of the International Conference on Genomics (ICG-21) was held at the BGI Center in Shenzhen from September 7 to 8. Under the theme “Bio- [...]
InnoCare Announces Approval of Clinical Trial of Novel Bispecific ADC ICP-B381 Targeting PSMA/ STEAP1 in China
09/09/2026
BEIJING, Sept. 08, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
XORTX Re-Engages Investor Relations Program
09/09/2026
CALGARY, Alberta, Sept. 08, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) announces that, following completion of its previously announced voluntary delisting from the TSX Venture [...]
HealthEx Empowers Consumers to Bring Their Personal Health History to Muse, Meta’s New Personal AI Agent
08/09/2026
Americans can connect their health history to Muse using HealthEx and make progress on their health goals with a plan that adapts to their life as their clinical context changes SAN FRANCISCO, Sept. 08, 2026 (GLOBE [...]
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
08/09/2026
– Assembly Bio to share 40% of U.S. development costs and profits for helicase-primase inhibitor program for recurrent genital herpes – – Cash runway remains projected into 2029, including the first $75 million [...]
Starton Therapeutics Appoints Experienced Finance Executive Saleem Elmasri, CPA, as Chief Financial Officer
08/09/2026
Experienced finance executive and former Big Four auditor to lead corporate finance strategy, and capital markets initiatives PARAMUS, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc . (“Starton”), a [...]
Inventiva présentera plusieurs abstracts lors du Congrès Paris MASH 2026
08/09/2026
Des données d’études cliniques de Phase 1 et Phase 2 montrent que le lanifibranor améliore le profil métabolique et certains facteurs de risque cardiovasculaire chez les patients atteints de MASH, avec ou sans diabète [...]
Inventiva to Present Multiple Abstracts at Paris MASH 2026
08/09/2026
Phase 1 and Phase 2 clinical data showed lanifibranor improves metabolic profile and cardiovascular risk factors in patients with MASH with or without type 2 diabetes Preclinical data further characterize lanifibranor’s [...]
Ascendis Pharma to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
COPENHAGEN, Denmark, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare [...]
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
08/09/2026
Event to be webcast live on September 9, 2026 at 7:30 a.m. ET BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for [...]
Keros Therapeutics Announces $5 Million Share Repurchase Authorization
08/09/2026
LEXINGTON, Mass., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel [...]
Celldex to Present at Upcoming Investor Conference
08/09/2026
HAMPTON, N.J., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in a fireside chat at the upcoming Cantor Global Healthcare Conference on September 10, 2026 at 8: [...]
Lakefront to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
08/09/2026
Mechelen, Belgium; 8 September 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the Morgan Stanley 24th Annual Global Healthcare [...]
Acquisition of Own Shares
08/09/2026
Mechelen, Belgium; 08 September 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]

Pages